A detailed history of Aimz Investment Advisors, LLC transactions in Incyte Corp stock. As of the latest transaction made, Aimz Investment Advisors, LLC holds 69,835 shares of INCY stock, worth $5.18 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares
69,835
Previous 70,935 1.55%
Holding current value
$5.18 Million
Previous $4.04 Million 4.75%
% of portfolio
1.53%
Previous 1.53%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$51.18 - $63.75 $56,298 - $70,125
-1,100 Reduced 1.55%
69,835 $4.23 Million
Q1 2024

May 10, 2024

BUY
$56.55 - $66.59 $473,549 - $557,624
8,374 Added 13.39%
70,935 $4.04 Million
Q4 2023

Jan 26, 2024

SELL
$52.16 - $64.19 $26,132 - $32,159
-501 Reduced 0.79%
62,561 $3.93 Million
Q3 2023

Nov 13, 2023

SELL
$57.77 - $65.93 $20,739 - $23,668
-359 Reduced 0.57%
63,062 $3.64 Million
Q2 2023

Aug 08, 2023

BUY
$60.95 - $75.51 $406,780 - $503,953
6,674 Added 11.76%
63,421 $3.95 Million
Q1 2023

May 15, 2023

SELL
$70.23 - $86.01 $2,458 - $3,010
-35 Reduced 0.06%
56,747 $4.1 Million
Q4 2022

Feb 10, 2023

SELL
$67.18 - $84.11 $26,872 - $33,644
-400 Reduced 0.7%
56,782 $4.56 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $33,090 - $41,430
500 Added 0.88%
57,182 $3.81 Million
Q1 2022

May 06, 2022

SELL
$66.02 - $79.71 $188,157 - $227,173
-2,850 Reduced 4.79%
56,682 $4.5 Million
Q4 2021

Feb 09, 2022

BUY
$63.34 - $74.11 $2.17 Million - $2.54 Million
34,222 Added 135.21%
59,532 $4.37 Million
Q3 2021

Nov 12, 2021

BUY
$68.67 - $84.02 $1.74 Million - $2.13 Million
25,310 New
25,310 $1.74 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Aimz Investment Advisors, LLC Portfolio

Follow Aimz Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aimz Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aimz Investment Advisors, LLC with notifications on news.